Clinical Trial Update: Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of GLPG2737 in male subjects with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• GLPG2737

Snippet

Sponsor: Galapagos NV | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED